BDTX

Conviction 8HealthcareScan · Thu, Jun 25, 2026

BDTX$1.69-9.14%

ResistanceSupportVol 14

Vol MA14 1.84M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Black Diamond Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.blackdiamondtherapeutics.com ↗

Price1.69

Change-9.14%

Gap+1.08%

Rel volume1.39×

Avg volume1.65M

Avg $ vol3.05M

SMA 201.89

SMA 502.47

SMA 2002.86

Price vs 50-31.66%

Price vs 200-40.82%

MA stackbearish

50/200 cross—

Supertrenddown · 2.13

RSI (14)37

MACD hist0.01

MACD crossbull · 1d

Stoch %K / %D17 / 21

ADX (14)23

+DI / −DI20 / 25

RSI divergence—

MACD divergenceBullish

ATR %+11.22%

ADR %7.38%

52w high4.87

52w low1.61

From 52w high-65.30%

Above 52w low+4.97%

New 52w highNo

SqueezeOff

Bollinger width46.19%

%B0.27

Donchian pos12.33%

Donchian high2.33

Donchian low1.60

AVWAP (52w high)2.67

vs AVWAP high-36.59%

AVWAP (52w low)1.74

vs AVWAP low-2.81%

OBV trendDown

Chaikin MF (20)-0.49

Today vs 20d1.39×

Avg vol (14d)1.84M

Avg vol (20d)1.65M

Avg $ vol (20d)3.05M

Market cap96.84M

RS 3m (vs SPY)-25.34%

RS 6m (vs SPY)-34.51%

RS line new highNo

Trend template0/8

Technical rank12.2

1 week+1.20%

1 month-27.47%

3 months-22.83%

6 months-35.00%

1 year-32.13%

YTD-32.13%

P/E4.33

P/B0.93

P/S—

P/FCF3.27

EPS0.3900

Div yield—

ROE21.44%

ROA16.83%

Debt/Eq—

Current8.46

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth132.10%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value66.77M

Revenue—

Net income-9.04M

Gross profit—

Free cash flow29.61M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out57.3M

Employees21

ListedThu, Jan 30, 2020

Free float41.48M

Float %72.8%

Short interest6.03M

Days to cover1.7d

Short volume38.2%

Squeeze score43 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$0.18 · 5 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction8 / 100

Pattern quality—

Tech rank12.2 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.58

Support1.93

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BDTX

All disclosures →

No recent disclosed trades by Congress in BDTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BDTX · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Behbahani Ali Director · Common Stock · 2026-06-19	Grant	8.96K	$15K	2026-06-19	2026-06-22
Raman Prakash Director · Common Stock · 2026-06-19	Grant	7.91K	$13K	2026-06-19	2026-06-22

SEC filings

EDGAR filings in BDTX

EDGAR →

No recent SEC filings on file for BDTX.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.